Enterprise Financial Services Corp continued to hold its stake in Thermo Fisher Scientific Inc. (NYSE:TMO) during the first quarter, according to its most recent filing with the SEC. The fund owned 1,985 shares of the medical research company’s stock at the end of the first quarter. Enterprise Financial Services Corp’s holdings in Thermo Fisher Scientific were worth $305,000 as of its most recent SEC filing.
Other large investors have also recently added to or reduced their stakes in the company. Independent Portfolio Consultants Inc. raised its stake in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Independent Portfolio Consultants Inc. now owns 730 shares of the medical research company’s stock worth $112,000 after buying an additional 2 shares during the last quarter. First Command Bank bought a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth $125,000. Advantage Investment Management LLC bought a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth $125,000. Cable Hill Partners LLC raised its stake in shares of Thermo Fisher Scientific by 27.1% in the third quarter. Cable Hill Partners LLC now owns 961 shares of the medical research company’s stock worth $152,000 after buying an additional 205 shares during the last quarter. Finally, Ancora Advisors LLC bought a new stake in shares of Thermo Fisher Scientific during the fourth quarter worth $176,000. Hedge funds and other institutional investors own 87.80% of the company’s stock.
Thermo Fisher Scientific Inc. (NYSE:TMO) opened at 171.53 on Friday. The firm’s 50-day moving average is $162.20 and its 200-day moving average is $152.72. Thermo Fisher Scientific Inc. has a 52-week low of $139.07 and a 52-week high of $173.53. The stock has a market cap of $67.11 billion, a P/E ratio of 31.29 and a beta of 1.10.
Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Wednesday, April 26th. The medical research company reported $2.08 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.02 by $0.06. The business had revenue of $4.77 billion for the quarter, compared to analysts’ expectations of $4.68 billion. Thermo Fisher Scientific had a net margin of 11.06% and a return on equity of 15.41%. The business’s quarterly revenue was up 10.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.80 earnings per share. Equities research analysts predict that Thermo Fisher Scientific Inc. will post $9.22 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, July 17th. Stockholders of record on Thursday, June 15th will be given a dividend of $0.15 per share. The ex-dividend date is Tuesday, June 13th. This represents a $0.60 annualized dividend and a dividend yield of 0.35%. Thermo Fisher Scientific’s dividend payout ratio is presently 11.79%.
ILLEGAL ACTIVITY WARNING: “Thermo Fisher Scientific Inc. (TMO) Position Maintained by Enterprise Financial Services Corp” was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are viewing this piece of content on another domain, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/05/20/thermo-fisher-scientific-inc-tmo-position-maintained-by-enterprise-financial-services-corp.html.
A number of equities research analysts recently weighed in on TMO shares. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “sell” rating to a “hold” rating in a report on Wednesday, February 1st. Evercore ISI lifted their price objective on shares of Thermo Fisher Scientific from $160.00 to $162.00 and gave the company a “buy” rating in a report on Tuesday, January 31st. Jefferies Group LLC decreased their price objective on shares of Thermo Fisher Scientific from $163.00 to $160.00 and set a “hold” rating for the company in a report on Monday, January 23rd. Morgan Stanley lifted their price objective on shares of Thermo Fisher Scientific from $186.00 to $192.00 and gave the company an “overweight” rating in a report on Friday, April 28th. Finally, Deutsche Bank AG lifted their price objective on shares of Thermo Fisher Scientific from $163.00 to $188.00 and gave the company a “buy” rating in a report on Friday, April 28th. Three investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $182.67.
In other news, CEO Marc N. Casper sold 20,000 shares of the stock in a transaction dated Wednesday, March 15th. The shares were sold at an average price of $158.60, for a total transaction of $3,172,000.00. Following the sale, the chief executive officer now owns 289,279 shares of the company’s stock, valued at $45,879,649.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter M. Wilver sold 9,987 shares of the company’s stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $158.18, for a total transaction of $1,579,743.66. Following the sale, the vice president now owns 77,233 shares in the company, valued at $12,216,715.94. The disclosure for this sale can be found here. Insiders have sold 57,964 shares of company stock worth $9,215,579 in the last three months. Corporate insiders own 0.52% of the company’s stock.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related companies with MarketBeat.com's FREE daily email newsletter.